ARGOS
ARGOS - ARtificial intelligence for Gross tumour vOlume Segmentation.
A study protocol for a federated multi-centre deep-learning neural network collaborative research project on lung cancer Gross Tumour Volume autosegmentation following the Personal Health Train method.
There is no funding agency that is explicitly funding this project at the moment. Participation
of each clinic is its own responsibility and therefore manages its own financial matters
independently.
The Project Lead
Partners
- Stichting Maastricht Radiation Oncology (Maastro), Maastricht, The Netherlands
- Katholieke Universiteit Leuven, Leuven, Belgium
- Radboud universitair medisch centrum, Nijmegen, The Netherlands
- Stichting Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, The Netherlands
- University Hospital Basel, Basel, Switzerland
- University Hospital Zurich, Zurich, Switzerland
- Universitair Medisch Centrum Groningen, Groningen, The Netherlands
- Stichting Isala Klinieken, Zwolle, The Netherlands
- Fudan University Shanghai Cancer Center, Shanghai, China
- Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
- Cancer Hospital of Shantou University Medical College, Shantou, China
- Gemelli Advanced Radiation Therapy Centre, Fondazione Policlinico Universitario, Rome, Italy
- Cardiff University, Cardiff, UK
- The Leeds Teaching Hospitals N.H.S. Trust, Leeds, UK
- The Christie NHS Foundation Trust, Manchester, UK
- Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
- Albert Einstein Israelite Hospital, Sao Paolo, Brazil
- University of Pennsylvania Medical Centre, Philadelphia, PA, USA
- H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA
- Liverpool Hospital, Liverpool, Australia
- MVR Cancer Centre and Research Institute, Khozikode, Kerala, India
- Medical Data Works B.V., Maastricht, The Netherlands